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1. Introduction
  Phyllanthus acidus (L.) Skeels (Euphorbiaceae) (P. 
acidus), commonly known as harfarauri or star gooseberry, 
is a widely distributed plant in India and other Asian 
countries. It is about 4-6 m high with obliquely ovate acute 
and distichous thin leaves. The leaf is analgesic, antipyretic, 
antirheumatic and cures jaundice, small pox, itching and 
gum infection. Traditionally it is used as liver tonic and 
blood purifier[1, 2]. The leaf decoction is used by tribal 
healers of Chittagong Hill Tracts region of Bangladesh to 
treat liver disease[3]. An aqueous extract of leaf is reported 
to have remarkable antiviral[4] and anti cystic fibrosis 
properties[5]. Studies with methanolic extract of P. acidus 
leaf have shown protection against carbon tetrachloride 
induced hepatotoxicity in rats[6]. Some important chemical 
constituents of the leaf include kaempferol, hypogallic acid, 
gallic acid, quercetin, and adenosine[5, 6].
  The aim of present study was to investigate and compare 
the hepatoprotective effects of crude ethanolic and aqueous 
extracts of P. acidus leaves on acetaminophen (APAP) and 
thioacetamide (TAA) induced acute liver toxicity in rats. 
The protective effects were compared with silymarin, a well 
known hepatoprotective against APAP and TAA induced 
hepatotoxicity[7].
2. Material and methods
2.1. Chemicals and drugs
  Acetaminophen, and 2,2-diphenyl-1-picrylhydrazil 
(DPPH) were purchased from Sigma Chemical Co. (St. 
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Louis, MO, USA). Thioacetamide was obtained from Loba 
Chemie, Mumbai. Silymarin was obtained as a gift sample 
from Serum International Ltd., Pune, India. Aspartate 
transaminase (AST), alanine transaminase (ALT), alkaline 
phosphatase (ALP), bilirubin and protein estimation kits 
were procured from Span Diagnostics, Surat, India. All other 
chemicals and reagents used were of highest commercially 
available purity and purchased from Qualigens, India.
2.2. Plant material 
  The fresh leaves of P. acidus were collected in May-June, 
2008 from University (Dr. H. S. Gour University) campus, 
Sagar (India) and authenticated in Botany Department of 
University, where a voucher specimen (No.Bot/H/4322) has 
been preserved for future reference. The leaves were shade 
dried, coarsely powdered and stored for further use. 
2.3. Preparation of extracts
2.3.1. Preparation of ethanolic extract
  The leaf powder (400 g) was sequentially extracted with 
petroleum ether (60-80 曟) and ethanol (95% v/v) till 
complete exhaustion using Soxhlet apparatus. The ethanolic 
extracts were filtered and the filtrate was evaporated 
to dryness at 50 曟 under reduced pressure in a rotary 
evaporator. About 14 g of dried ethanolic extract was 
obtained from 400 g of dried leaf powder (3.5% w/w). The 
extract was uniformly suspended in 2% aqueous gum acacia 
prior to experiment.
2.3.2. Preparation of aqueous extract
  500 g leaf powder was subjected to hot water extraction for 
4 h at 80 曟 and then filtered. The filtrate was evaporated to 
dryness to get the water extract. The yield of extract was 33 g 
from 500 g of leaf powder (6.6% w/w). This crude extract was 
re-suspended in water prior to experiment.
2.4. Preliminary phytochemical screening
  Preliminary phytochemical analysis on plant extracts was 
performed using the following chemicals and reagents: 
flavonoids (Mg metal and HCl), phenolics (FeCl3), protein 
and amino acid (Millon’s and Ninhydrin reagent), alkaloids 
(Mayer and Dragendorff’s reagent), saponins (Foam test), 
phytosterols and triterpenoids (Liebermann- Burchard Test) 
and glycosides (NaCl and Fehling’s solution A and B) [8].
2.5. Animals
  Wistar albino rats (200-220 g) and Swiss albino mice (20-
25 g) of either sex were used for the studies. The animals 
were grouped and housed in polyacrylic cages with not more 
than six per cage and maintained under standard laboratory 
conditions of temperature [(25依2) 曟] and relative humidity 
[(55依5) %] with dark and light cycle (12/12 hours). They 
were acclimatized to laboratory conditions for 7 days before 
commencing the experiment and allowed for free access to 
standard pellet diet (Him Feed H.P., Agro industries) and 
water ad libitum. Animal studies were approved by the 
Institutional Animal Ethics Committee (379/01/ab/CPCSEA) 
and conducted as per the regulations of Committee for the 
Purpose of Control and Supervision of Experiments on 
Animals (CPCSEA).
2.6. Acute oral toxicity studies
  The acute oral toxicity studies of P. acidus extracts were 
carried out as per OECD guidelines[9]. On the basis of these 
studies, the oral doses of 200 and 400 mg/kg, bw were 
selected for the in vivo experiments.
2.7. Total phenol and flavonoid content determination
  The total phenol content of plant extracts was determined 
by Folin-Ciocalteau method[10]. The total phenolic content 
was expressed as milligrams of gallic acid equivalents/g 
extract (mg GAE/g of dry mass).
  The flavonoid content of extracts was estimated as 
quercetin equivalent[11]. The total flavonoid content was 
expressed in milligrams of quercetin equivalents/g of extract 
(mg QE/g of dry mass).
2.8. DPPH scavenging assay
  The free radial scavenging (antioxidant) property of extracts 
was determined as bleaching of the stable DPPH radical[12].
Ascorbic acid, a well known antioxidant was used as a 
positive control. 
2.9. APAP- induced hepatotoxicity
  The experiment was conducted according to the method 
described previously[13]. Rats were randomly divided into 7 
groups, each consisting of 6 rats. Group 栺 served as normal 
control and received distilled water (1 mL/kg, po.) daily for 
7 days and 50% aqueous sucrose (10 mL/kg, po.) on days 
5. Group 栻 served as hepatotoxicity  (APAP) control and 
received distilled water (1 mL/kg, po.) daily for 7 days and 
received APAP (2 g/kg, po.) as suspension in 50% aqueous 
sucrose solution on days 5. Group 栿 was treated with 
silymarin (100 mg/kg, po.) daily for 7 days and received 
APAP (2 g/kg, po.) on days 5, 30 min after the administration of 
silymarin. Groups 桇-桋 and 桍-桏 were treated with ethanolic 
and aqueous extracts at two doses (200 and 400 mg/kg, po.), 
respectively, for 7 days and received APAP (2 g/kg, po.) on 
days 5, 30 min after administration of extracts.
2.10. TAA- induced hepatotoxicity
  Rats were randomly divided into 7 groups, each consisting 
of 6 rats. Group 栺 served as normal control and received 
distilled water (1 mL/kg, po.) daily for 7 days. Group 栻
served as hepatotoxicity (TAA) control and received distilled 
water (1 mL/kg, po.) daily for 7 days and received TAA (100 
mg/kg, sc.) as 2% w/v solution in distilled water on days 6[14].
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Group 栿 was treated with silymarin (100 mg/kg, po.) daily 
for 7 days and received TAA (100 mg/kg, sc.) on days 6, 30 
min after administration of silymarin. Groups 桇-桋 and 桍
-桏 were treated with ethanolic and water extracts at two 
doses of 200 and 400 (mg/kg, po.), respectively, for 7 days 
and received TAA (100 mg/kg, sc.) on days 6, 30 min after the 
administration of extracts.
2.11. Biochemical assay
  On the 7th day, under ether anesthesia, blood samples were 
taken from retro-arbitral plexus of rats. The blood samples 
were allowed to clot for 30 min and serum was separated by 
centrifugation at 3 000 rpm at 4 曟. 
  The activities of serum ALT and AST[15] and ALP[16] were 
determined. Total bilirubin[16] and protein content[17] 
were also determined in serum to assess the acute hepatic 
injuries.
2.12. Statistical analysis
  The results of study are expressed as mean依standard 
error mean (SEM) and statistically analyzed using one-
way ANOVA followed by Dunnett’s test for comparison with 
normal control group and hepatotoxin control group. P < 0.05 
was considered to be statistically significant. 
3. Results
3.1. Preliminary phytochemical analysis
  On preliminary phytochemical analysis, the ethanolic 
extracts of P. acidus showed the presence of flavonoids, 
glycosides, phenolic compounds, phytosterols and saponins, 
whereas the aqueous extract revealed the presence of 
flavonoids, glycosides, phenolic compounds, proteins, amino 
acids, carbohydrates and saponins.
3.2. Acute oral toxicity study
  In acute oral toxicity studies, the P. acidus extracts did not 
show any sign and symptoms of toxicity and mortality up to 
2 000 mg/kg dose, considered relatively safe. 
3.3. Total phenolic and flavonoid content
  The phenolic and flavonoid contents were found maximum 
in aqueous extract (175.02依4.35 and 74.68依1.28, respectively) 
than compare to ethanolic extract (96.05依2.51 and 59.25依
1.09, respectively).
3.4. DPPH scavenging activity
  The aqueous extract of P. acidus has better scavenging 
property [IC50=(33.2依0.31) 毺g/mL] than ethanolic extract 
[IC50 =(69.6依0.23) 毺g/mL]. The IC50 value of ascorbic acid 
(reference antioxidant) was found to be (21.8依0.34) 毺g/mL.
3.5. Effect of P. acidus extracts on APAP- induced 
hepatotoxicity
  As shown in Table 1, APAP control rats (group 栻) showed 
significant increase in serum AST (2.7 fold), ALT (2.9 fold), 
ALP (2.4 fold) and bilirubin (6.3 fold) levels and a significant 
decrease in serum total protein (1.52 fold) in comparison 
with normal control rats. On the other hand, administration 
of both extracts of P. acidus at two dose levels (200 and 400 mg/kg,
po.) attenuated the increased levels and caused a 
subsequent recovery towards normalization. Pretreatment 
of rats with aqueous extract (400 mg/kg, po.) showed highly 
significant activity (P<0.01 and 0.001) almost like that of 
silymarin (100 mg/kg, po.) (Table 1).
3.6. Effect of P. acidus extracts on TAA induced 
hepatotoxicity
  The results of hepatoprotective effect of P. acidus leaf 
extracts on TAA-intoxicated rats are shown in Table 2. 
In TAA control rats, a marked increase in serum AST (2.7 
fold), ALT (3 fold), ALP (2 fold) and total bilirubin (5 fold) 
was observed in comparison with normal control rats. 
Table 1
Effect of P. acidus leaf extracts and silymarin on serum markers on acetaminophen (APAP, 2 g/kg, po.)- induced hepatotoxicity in Wistar rat.
Groups Treatment AST (IU/L) ALT (IU/L) ALP (IU/L)
Total bilirubin
(mg/dL)
Total serum protein
 (mg/dL)
Group 栺 Normal (distilled water)   66.52依 0.69   36.54依 0.87 135.59依 3.32 0.36依 0.28 6.12依 0.09
Group 栻 APAP (2 g/kg, po.) 178.89依1.98
# 105.68依1.57 # 318.68依 6.08 # 2.28依 0.08# 4.02依 0.04 #
Group 栿 Silymarin (100 mg/kg, po.)   81.67依1.29
*  (86.51)   43.68依1.87 *(89.67) 191.87依 9.68 *(69.26) 0.57依 0.06*(89.00) 6.25依0.15 *(106.19)
Group 桇 Ethanolic extract (200 mg/kg, po.) 136.58依2.34  (37.65)   79.37依1.92 
☆(38.00) 272.63依 3.55 ☆(46.05) 1.34依0.04 ☆(46.95) 5.09依0.06☆(50.95)
Group 桋 Ethanolic extract (400 mg/kg, po.) 109.35依1.57荭  (61.89)   61.29依1.28 荭(64.20) 223.54依 1.94 荭(51.96) 1.16依0.05荭(58.33) 5.28依 0.05荭(60.00)
Group 桍 Aqueous extract (200 mg/kg, po.) 107.64依0.97荭  (63.40)   69.18依0.67 荭(52.79) 242.87依 2.87 
☆(41.40) 1.09依 0.02荭(61.97) 5.22依 0.01☆(57.14)
Group 桏 Aqueous extract (400 mg/kg, po.)   96.85依1.18 
* (73.00)   45.42依 0.81*(87.15) 198.54依 1.89 *(65.61) 0. 72依0.02 *(81.25) 5.95依 0.01*(91.90)
F -values 56.53 198.31 61.23 21.23 26.87
Values are mean 依 SEM, n = 6 animals per group. #group 栻 (APAP control rats) compared with group 栺 (normal control rats) P < 0.001; 
* groups 栿-桇 (silymarin and plant extracts treated rats) compared with group 栻 (APAP control rats) P < 0.001; △groups 栿-桏(silymarin 
and plant extracts treated rats) compared with group 栻 (APAP control rats) P < 0.01; ☆groups 栿-桏 (silymarin and plant extracts treated rats) 
compared with group 栻(APAP control rats) P < 0.05.Values in the parenthesis indicate percent protection in individual biochemical parameters 
from their elevated values caused by the hepatoprotection. The percentage of the protection is calculated as 100 伊 (values of APAP control - 
values of sample) / (values of APAP control - values of normal control).
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Such elevated levels were substantially prevented in rats 
pretreated with P. acidus  extracts. The aqueous extract 
(400 mg/kg, po.) showed remarkable protection on TAA 
hepatotoxicity but not as effective as the silymarin.
4. Discussion
  APAP and TAA-induced hepatic injuries are commonly 
used screening models for new hepatoprotective drugs[18, 19].
APAP is a well known analgesic-antipyretic and is known to 
cause severe hepatic damage in humans and experimental 
animals with high doses. Its toxicity is attributed to formation 
of reactive metabolite viz. N-acetyl-p-benzoquinoneimine 
(NAPQI) by the action of cytochrome P-450 (CYP-450) 
enzyme system[20]. TAA is a potent hepatotoxic and 
hepatocarcinogenic compound, which is bioactivated by 
CYP-450 and/or flavin-containing monooxygenases system 
to form reactive metabolites viz. sulfene (sulfone) and sulfine 
(sulfoxide). These reactive metabolites initiate the generation 
of reactive oxygen species and leads to hepatocellular death 
via oxidative stress[21].
  An indication of hepatic damage is leakage of cellular 
enzymes into the plasma. When liver cell membrane is 
damaged, a variety of cytosolic enzymes are released into 
the blood stream. Their estimation in serum is a useful 
quantitative marker of the extent and type of hepatocellular 
damage[22]. The elevated levels of AST and ALT in this study 
may be interpreted as a result of the hepatocytes damage 
or alterations in the membrane permeability indicating the 
severity of hepatocellular damage induced by APAP and 
TAA which is in accordance with previous reports[23, 24].
Pretreatment with P. acidus extracts attenuated the 
increased activities of these enzymes in serum. Recovery 
towards normalization suggests that P. acidus extracts 
prevent hepatic cellular damage, thereby, decreasing the 
enzyme leakage. In contrast, an increase in ALP activity and 
bilirubin level reflects the pathological alteration in biliary 
flow. Likewise their suppression in extract treated rats 
suggests the possibility of the extracts being able to stabilize 
biliary dysfunction.
  On comparing the both extracts, aqueous extract was found 
to be stronger hepatoprotective than the corresponding 
ethanolic extract against both toxicants. Its hepatoprotective 
activity was comparable with that of silymarin. The DPPH 
scavenging activity was also found maximum with aqueous 
extract, which suggests that it could scavenge efficiently 
the free radicals generated during the APAP and TAA 
metabolism. In our preliminary phytochemical screening, 
the ethanolic extract revealed the presence of polyphenolic/
saponins/steroids as major compounds; meanwhile the 
aqueous extract showed the presence of protein in addition 
to polyphenolics/saponins/flavonoids as major compounds. 
The protein isolated from P. niruri has been shown as a 
protective agent against xenobiotic induced hepatotoxicity [21, 25].
Phytochemical analysis also revealed the high content of 
phenolics and flavonoids in aqueous extract, which might 
be responsible for its stronger biological activities, because 
these phytochemicals were identified as strong antioxidants 
in other Phyllanthus species[26, 27].
  The hepatoprotective and antioxidant properties of 
several Phyllanthus aqueous extracts have already been 
demonstrated[28-36]. The literature also documented the 
antioxidant and hepatoprotective value of gallic acid and 
quercetin[37,38]. The antioxidant property of P. acidus 
leaf extract against CCl4-induced hepatotoxicity in mice 
has already been reported[7]. Thus, it appears that the 
hepatoprotection offered by P. acidus aqueous extract might 
be associated with such identified classes of compounds and 
antioxidative properties.
  In conclusion, the results of the present study indicated 
that under experimental conditions, the aqueous extract of 
P. acidus leaves has significant hepatoprotective capacity 
against APAP and TAA induced hepatotoxicity. Further 
investigations on isolation and characterization of the active 
compounds responsible for the offered hepatoprotection by 
P. acidus aqueous extract are under way in our laboratory.
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Table 2 
Effect of P. acidus leaf extracts and silymarin on serum markers on thioacetamide (TAA, 100 mg/kg, sc.)- induced hepatotoxicity in Wistar rats
Groups Treatment      AST (IU/L)       ALT (IU/L)        ALP (IU/L)
     Total bilirubin
           (mg/dL)
Total serum protein
        (mg/dL)
Group 栺 Normal (distilled water)   52.53依 0.35 32.43依 0.45 142.59依 2.16 0.42依 0.21 8.15依 0.06
Group 栻 TAA (100 mg/kg, sc.) 138.94依1.27 
# 98.63依 1.99 # 278.69依 5.04 # 2.13依 0.06 # 3.73依 0.05 #
Group 栿 Silymarin (100 mg/kg, po.)   63.62依1.31 
* (87.15) 49.79依 1.82 *(73.80) 165.62依 7.86 *(83.07) 0.45依 0.02 * (98.24) 8.22依 0.18 *(101.58)
Group 桇 Ethanolic extract (200 mg/kg, po.) 106.52依1.67(37.51) 65.57依 1.25 
☆(49.90) 216.25依 4.37 ☆(45.87) 1.36依 0.05 ☆(45.02) 4.95依 0.24 ☆(27.66)
Group 桋 Ethanolic extract (400 mg/kg, po.)   97.41依1.54 
△(48.00) 58.32依  1.36 
*(60.89) 198.68依 3.53 △(58.78) 1.12依 0.01△ (59.06) 5.62依 0.06 △(42.76)
Group 桍 Aqueous extract (200 mg/kg, po.)   99.65依0.86 
△(45.46) 66.15依 0.59 ☆(49.00) 201.81依 1.86 △ (56.48) 1.08依 0.01△ (61.40) 5.47依 0.01△(39.36)
Group 桏 Aqueous extract (400 mg/kg, po.)   79.46依1.22 
*(68.90) 52.84依 0.67 *(69.63) 176.54依 1.92 *(75.00) 0.82依 0.02 * (76.60) 6.53依 0.01*(56.56)
F -values   64.27 208.17 64.28 39.43 20.34
Values are mean 依 SEM., n = 6 animals per group. #group 栻 (APAP control rats) compared with group I (normal control rats) P < 0.001; 
* groups 栿-桏 (silymarin and plant extracts treated rats) compared with group 栻(APAP control rats) P < 0.001; △groups 栿-桏 (silymarin 
and plant extracts treated rats) compared with group 栻 (APAP control rats) P < 0.01; ☆groups 栿-桏 (silymarin and plant extracts treated rats) 
compared with group 栻 (APAP control rats) P < 0.05.Values in the parenthesis indicate percent protection in individual biochemical parameters 
from their elevated values caused by the hepatoprotection. The percentage of the protection is calculated as 100 伊 (values of APAP control - 
values of sample) / (values of APAP control - values of normal control).
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